PANADRON PLUS XL 2CPR

active ingredients

Each tablet contains active ingredients: praziquantel 175 mg; pirantel emboned 504 mg (equivalent to 175 mg pirantel); febantel 525 mg. Excipients: for the complete list of excipients, see paragraph 6.1.

Excellent

Cellulose microcrystalline, magnesium stearate, colloidal silica anidra, sodium croscarmelloso, sodium laurilsolfato, aroma of pork.

Contraindications

Do not use hypersensitivity to active ingredients or one of the excipients. Do not administer during the first and second trimester of pregnancy (see paragraph 4.7).

Population

Only for oral administration. In order to ensure proper dose administration, body weight should be determined as accurately as possible. Dosage: for the treatment of dogs, 1 tablet for 35 kg body weight (15 mg febantel, 14,4 mg pirantel embonate and 5 mg praziquantel/kg body weight). The dosages are as follows. Body weight (kg): about 17.5 kg; tablets: 1⁄2 panadron plus xl tablets for dogs. Body weight (kg): 31-35 kg; tablets: 1 panadron plus xl tablets for dogs. Body weight (kg): >35-40 kg; tablets: 1 panadron plus xl tablets for dogs + 1⁄2 panadron plus tablet for dogs. Body weight (kg): >40-45 kg; tablets: 1 panadron plus xl tablets for dogs + 1 panadron plus tablet for dogs. Body weight (kg): >45-50 kg; tablets: 1 panadron plus xl tablets for dogs + 1 1⁄2 panadron plus tablet for dogs. Body weight (kg): >50-55 kg; tablets: 1 panadron plus xl tablets for dogs + 2 panadron plus tablet for dogs. Body weight (kg): >55-60 kg; tablets: 1 panadron plus xl tablets for dogs + 2 1⁄2 panadron plus tablet for dogs. Body weight (kg): >60-65 kg; tablets: 1 panadron plus xl tablets for dogs + 3 panadron plus tablet for dogs. Body weight (kg): >65-70 kg; tablets: 2 panadron plus xl tablets for dogs. Tablets can be administered directly to the dog or hidden in food. You don't need a fasting period, either before or after treatment. Tablets should be given in a single administration. The parts of tablets should be removed immediately or placed in the blister open until use. If there is a risk of re-infestation, contact a veterinarian to request information on the need and frequency of other administrations.

Conservation

This veterinary medicinal product does not require any special conservation conditions. The unused half tablets must be placed in the appropriate space in the open blister and stored in the cardboard box. Validity period of the veterinary medicinal product packaged for sale: five years. The unused half tablets should be used within 14 days.

Warnings

Fleas are intermediate guests of a common type of tenia, called Dipylidium caninum. Tenie infestation will certainly resume if there are no control measures on intermediate guests, such as fleas, mice, etc. Special precautions for use in animals: the resistance of a parasite to a particular class of anti-elmintics can develop following the frequent use, repeated of an anti-elmintic of such class. To reduce the risk of re-infestation and new infestations, the feces would be collected and eliminated appropriately within 24 hours of treatment. Special precautions to be adopted by the person administering the veterinary medicinal product to animals: in case of accidental ingestion, immediately turn to a doctor showing him the leaflet or label. In compliance with hygiene standards, wash your hands after administering the tablets directly to the dog or after adding them to his food. Other precautions: the veterinary medicinal product is effective against Echinococcus spp. which is not present in all European countries but is becoming increasingly common. Echinococcosis is a danger to men. Considering that echinococcosis is a pathology known to the World Organization for Animal Health (OIE), specific guidelines on treatment and control, and the safeguarding of persons, it is necessary to be provided by relevant competent authorities. In safety studies, a single dose equal to 5 times the recommended or higher dose of praziquantel, plow embonate caused occasional vomiting. Main incompatibility: not relevant.

Interactions

Do not simultaneously administer piperazine compounds as the anti-elmintic effects of pirantel and piperazin may be antagonized. Concurrent use of other colinergic compounds can cause toxicity.

Source: Farmadati